Posted Sep. 14, 2012 at 6:56 a.m.

Premium Lock FDA advisory panel rejects new Cornerstone drug

Published: 2012-09-14 06:56:13
Updated: 2012-09-14 06:56:13

FDA FDA

An advisory panel to the Food and Drug Administration today gave a no confidence vote for a Cornerstone Therapeutics compound developed to treat low salt levels in the blood....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Scroll